Medicare Enrolled
Dr. Frederick Wood, MD
Cardiovascular Disease · Murrieta, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wood from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wood?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wood
Dr. Frederick Wood is a cardiovascular disease specialist in Murrieta, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wood performed 4,705 Medicare services across 2,496 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wood received a total of $18,354 from 41 pharmaceutical and/or device companies across 1061 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wood is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 22% volume in CA
$18,354 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,705
Medicare services
Top 22% in CA for cardiovascular disease
2,496
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~248 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,295 | $94 | $281 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
447 | $68 | $191 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
226 | $13 | $46 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
182 | $154 | $612 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
172 | $13 | $31 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
163 | $8 | $8 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
163 | $2 | $8 |
| Red blood cell concentration measurement A laboratory test that measures the concentration of red blood cells in the blood. |
162 | $2 | $8 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
156 | $43 | $133 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
155 | $61 | $154 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
148 | $76 | $331 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
117 | $11 | $45 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
117 | $1 | $1 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
112 | $158 | $515 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
90 | $67 | $100 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
86 | $69 | $420 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
75 | $49 | $69 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
65 | $51 | $222 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
65 | $64 | $186 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
62 | $61 | $240 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
57 | $15 | $72 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
51 | $24 | $87 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
50 | $19 | $70 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
49 | $368 | $1,315 |
| 2-day continuous ECG monitoring with report This procedure involves continuous electrocardiogram monitoring over a two-day period to record heart activity. A report is provided to summarize the findings from the monitoring session. |
47 | $30 | $103 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
47 | $15 | $70 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
43 | $80 | $238 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
36 | $58 | $245 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
34 | $205 | $619 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
33 | $18 | $53 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
29 | $10 | $39 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
28 | $152 | $505 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
28 | $153 | $600 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
27 | $21 | $66 |
| New patient office visit, complex (60-74 min) | 24 | $166 | $537 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
22 | $83 | $215 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
21 | $21 | $83 |
| Ultrasound of arm arteries or grafts This procedure uses sound waves to create images of the blood vessels in the arm or any grafts present. It allows for the visualization of blood flow and vessel structure. |
21 | $155 | $576 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.2% high complexity
16.2% medium
69.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,354
Total received (2018-2024)
Avg $2,622/year across 7 years
Top 19% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,061
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,261 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$93 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,500
2023
$2,637
2022
$2,560
2021
$3,042
2020
$2,684
2019
$2,432
2018
$2,498
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$366
Novartis Pharmaceuticals Corporation
$347
AstraZeneca Pharmaceuticals LP
$338
SANOFI-AVENTIS U.S. LLC
$259
Lexicon Pharmaceuticals, Inc.
$176
PFIZER INC.
$156
Janssen Pharmaceuticals, Inc
$153
Merck Sharp & Dohme LLC
$132
Novo Nordisk Inc
$115
Amgen Inc.
$110
Actelion Pharmaceuticals US, Inc.
$93
E.R. Squibb & Sons, L.L.C.
$80
Kiniksa Pharmaceuticals International, plc
$47
Daiichi Sankyo Inc.
$43
Abbott Laboratories
$39
Lilly USA, LLC
$32
Esperion Therapeutics, Inc.
$15
Top 3 companies account for 42.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,017
AstraZeneca Pharmaceuticals LP
$1,907
Janssen Pharmaceuticals, Inc
$1,739
Amarin Pharma Inc.
$1,452
SANOFI-AVENTIS U.S. LLC
$1,434
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,391
PFIZER INC.
$1,336
Amgen Inc.
$996
E.R. Squibb & Sons, L.L.C.
$987
Esperion Therapeutics, Inc.
$539
Novo Nordisk Inc
$457
Abbott Laboratories
$434
Merck Sharp & Dohme LLC
$430
NOVARTIS PHARMACEUTICALS CORPORATION
$361
Regeneron Healthcare Solutions, Inc.
$313
ARBOR PHARMACEUTICALS, INC.
$280
CVRx, Inc.
$272
Kowa Pharmaceuticals America, Inc.
$240
Impulse Dynamics (USA) Inc.
$216
Lexicon Pharmaceuticals, Inc.
$176
BIOTRONIK INC.
$163
Allergan Inc.
$142
Azurity Pharmaceuticals, Inc.
$133
Boston Scientific Corporation
$114
Arbor Pharmaceuticals, Inc.
$113
Merck Sharp & Dohme Corporation
$109
Actelion Pharmaceuticals US, Inc.
$107
ATRICURE, INC.
$87
Kiniksa Pharmaceuticals, Ltd.
$69
Edwards Lifesciences Corporation
$59
Kiniksa Pharmaceuticals International, plc
$47
Tactile Systems Technology Inc
$44
Daiichi Sankyo Inc.
$43
Lilly USA, LLC
$32
iRhythm Technologies, Inc.
$25
Gilead Sciences, Inc.
$18
Medtronic, Inc.
$17
Medtronic Vascular, Inc.
$16
Bardy Diagnostics, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Akcea Therapeutics, Inc.
$11
Top 3 companies account for 30.9% of all-time payments
Associated products mentioned in payments ›
ATRICLIP LAA EXCLUSION SYSTEM · Arcalyst · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CardioMEMS HF System · Carnation Ambulatory Monitor · Confirm Rx · Connectivity and Remote care · Corlanor · Delivery Systems · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · General - Therapies · Horizant · INJECTAFER · JARDIANCE · JOT DX · Kerendia · LATITUDE Communicator Power Supply · LEQVIO · LINQ II · LOKELMA · Livalo · MITRACLIP · MOUNJARO · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · NEXLETOL · NEXLIZET · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · RYBELSUS · Repatha · Reveal LINQ · Rybelsus · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · VYNDAMAX · Vascepa · WAINUA · WATCHMAN Access System · Wegovy · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
71
Per 100K population
2.9
County median income
$89,672
Nearest hospital
SOUTHWEST HEALTHCARE RANCHO SPRINGS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wood is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wood experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wood performed 1,295 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wood receive payments from pharmaceutical companies?
Yes. Dr. Wood received a total of $18,354 from 41 companies across 1,061 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wood's costs compare to other cardiologists in Murrieta?
Dr. Wood's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wood) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Murrieta
Browse cardiologists in Murrieta ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology